OSANG Healthcare Co. Ltd.
OSANG Healthcare has been a leader in the Korean IVD (In-Vitro Diagnosis) industry since its founding in 1996, expanding a wide array of medical devices for Biochemical, Immunoassay, and Molecular Diagnostics.
OSANG Healthcare Co., was the first South Korean SARS-CoV-2 test kit producer to receive authorization from the U.S. Food & Drug Administration in April 2020. The company has supplied countries from Brazil to Russia and also sold 760,000 tests to U.S. customers, including FEMA.